ECOR (electroCore) Total Long-Term Assets: $2.94 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ECOR electroCore Inc ECOR
76 GF Score
Price $9.73
GF Value $8.64
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is electroCore Total Long-Term Assets?

electroCore ECOR -8.36% 76 Total Long-Term Assets is $2.94 Mil as of Jun. 2026. GuruFocus rates ECOR with a GF Score™ of 76/100 and a GF Value™ of $8.64 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. electroCore's Total Long-Term Assets for the quarter that ended in Jun. 2026 was $2.94 Mil.

electroCore Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for electroCore's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

electroCore Total Long-Term Assets Chart

electroCore Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.29 3.58 1.81 4.17 3.00

electroCore Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.07 3.00 2.96 2.94
ECOR
76GF Score
electroCore Inc ECOR
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

electroCore Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $2.94 Mil mean?
electroCore (ECOR) has a Total Long-Term Assets of $2.94 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on electroCore and its competitors.
Is electroCore's Total Long-Term Assets too high?
electroCore's current Total Long-Term Assets is $2.94 Mil. Overall, electroCore has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does electroCore's Total Long-Term Assets compare to COCH and MDAI?
electroCore's Total Long-Term Assets of $2.94 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on electroCore and its competitors. electroCore's current Total Long-Term Assets is $2.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is electroCore stock overvalued right now?
Based on GuruFocus' analysis, electroCore (ECOR) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.64, compared to a current price of $9.73 — trading 12.6% above its estimated fair value. The current Total Long-Term Assets is $2.94 Mil. electroCore's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For electroCore (ECOR), the current Total Long-Term Assets is $2.94 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is electroCore (ECOR) Overvalued in 2026?

Based on GuruFocus' analysis, electroCore stock appears to be overvalued. The current stock price of $9.73 is trading 12.6% above its estimated GF Value™ of $8.64. GuruFocus considers electroCore to be Modestly Overvalued.

Key valuation signals for ECOR:

  • Total Long-Term Assets: $2.94 Mil
  • GF Value™: $8.64 vs. price of $9.73 (12.6% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the ECOR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

electroCore Business Description

Other Exchanges 43E0:Germany
Address 200 Forge Way, Suite 205, Rockaway, NJ, USA, 07866
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
76GF Score

Get the complete analysis for ECOR

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.73
Price
$8.64
GF Value